1 Product identity
Ingredient risk
1 ingredient to use with caution

Marcozyme

BrandMarco Pharma Int'l→Other Combinations Tablet or Pill 11 ingredients 1 caution DSLD #25334
Net contents: 250 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-09-25
2 Ingredients (11)
IngredientGroupSafety
PancreatinBlend (Combination)—
PapainPapainConditionally Safe
BromelainBromelainConditionally Safe
RutinRutin—
TrypsinTrypsin—
ChymotrypsinChymotrypsin—
Magnesium AspartateMagnesiumUse with Caution
Dicalcium PhosphateCalciumConditionally Safe
CelluloseCellulose—
Stearic AcidStearic Acid—
Contains less than 1% ofHeader—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Papain — Conditionally Safe
⚠ Allergic reactions
⚠ Increased bleeding risk
Bromelain — Conditionally Safe
⚠ Increased bleeding risk
⚠ GI upset
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID25334
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-09-25
6 More from Marco Pharma Int'l
View Marco Pharma Int'l Safety Scorecard → 15 products
AccelerinBa-Co-FlorBa-Co-FlorCerebro PTCColostrumEnerdreen
7 Cite this page
Vancouver
Pkhakadze G. Marcozyme — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/dsld-25334/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG